Segmentation Analysis, Market Trends, and Competitive Landscape in the Deoxyribonucleic Acid (DNA) Manufacturing Market

The field of DNA manufacturing is on the brink of impressive expansion, driven by cutting-edge technological advancements and growing demand across therapeutic and research sectors. As the industry evolves, it is essential to explore the projected market size, key players, influential trends, and the diverse segments shaping this rapidly developing landscape.

Projected Growth and Market Size in the DNA Manufacturing Sector
The global DNA manufacturing market is set to experience significant growth, with its value forecasted to reach $11.95 billion by 2030. This reflects a robust compound annual growth rate (CAGR) of 16.4% during the forecast period. Several factors contribute to this surge, including improvements in enzymatic and chemical DNA synthesis methods, expansion in gene therapy and vaccine development pipelines, and increased uptake of GMP-grade DNA production. Additionally, the rising demand for longer and more complex DNA constructs, alongside the integration of automated manufacturing platforms and digital workflows, is expected to drive this market forward. During this timeframe, key trends will include heightened demand for GMP-grade DNA in therapeutic applications, growth in plasmid and synthetic DNA production for vaccines, broader adoption of gene synthesis and codon optimization services, and expanded oligonucleotide synthesis for PCR, siRNA, and antisense technologies. The incorporation of DNA manufacturing within cell and gene therapy pipelines also stands out as a vital growth factor.

Download a free sample of the deoxyribonucleic acid (dna) manufacturing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Industry Players Driving the DNA Manufacturing Market
The DNA manufacturing market is characterized by the presence of several prominent companies, including Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., and PlasmidFactory GmbH & Co. KG.

Strategic Acquisitions Enhancing Market Capabilities
A notable development occurred in February 2025 when Maravai LifeSciences Holdings, Inc., a U.S.-based life sciences company, acquired Officinae Bio S.r.l., an Italian biotech firm specializing in AI-powered platforms for DNA and RNA therapeutic design. This acquisition aims to merge Officinae's AI-enabled mRNA and DNA sequence design platform with Maravai's TriLink nucleic acid production services, accelerating the creation of next-generation nucleic acid therapies and enhancing the company's innovation capabilities.

View the full deoxyribonucleic acid (dna) manufacturing market report:
https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Influencing the Future of DNA Manufacturing
Leading organizations in the DNA manufacturing market are increasingly focusing on producing GMP-grade plasmid DNA to improve the safety, quality, and scalability of gene and cell therapies. The GMP-grade designation ensures compliance with strict regulatory standards that guarantee consistent biopharmaceutical product quality. This focus on high standards is essential to meet the growing demands of clinical and commercial applications.

An example of innovation in this area is ProBio Genomics Inc., a U.S.-based contract development and manufacturing organization (CDMO), which in April 2025 launched GMP Plasmid DNA Manufacturing Services in Hopewell. Their offering includes in-house analytical testing, method development, and comprehensive project management-streamlining processes by reducing reliance on multiple suppliers. This service guarantees high-quality output with =85% supercoiled plasmid DNA content while minimizing contamination risks. Additionally, they provide GMP-like plasmids with a four-week turnaround and full GMP-grade plasmids within three months, accelerating development timelines for clients.

Detailed Market Segmentation of the DNA Manufacturing Industry
This market can be analyzed through various segments, each reflecting specific aspects of DNA manufacturing:

1) By Type:
- Plasmid DNA
- Synthetic DNA
- Gene Synthesis
- Oligonucleotide Synthesis

2) By Grade:
- Good Manufacturing Practices (GMP) Grade
- Research and Development Grade

3) By Application:
- Cell and Gene Therapy
- Vaccines
- Oligonucleotide-Based Drugs
- Other Applications

4) By End-Use:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations

Further subcategories provide a more granular view:

- Plasmid DNA includes GMP-grade and non-GMP-grade plasmids, high and low copy number plasmids, bacterial fermentation-based plasmid production, and transfection-grade plasmid DNA.
- Synthetic DNA spans enzymatic and chemical synthesis methods, long and short DNA fragments, single- and double-stranded synthetic DNA.
- Gene synthesis covers custom and standard gene synthesis, complex gene constructs, codon optimization services, and gene library synthesis.
- Oligonucleotide synthesis consists of DNA oligonucleotides, modified oligonucleotides, long oligonucleotides, PCR primers, siRNA and antisense oligos, as well as adapter and linker oligos.

This segmentation provides a comprehensive framework to understand the structure and key drivers of the DNA manufacturing market as it advances toward 2030.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.